Intelligence Platform
Patents
Browse 565 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8299100
Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane perm
granted patentUS 8278084
Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide
granted patentUS 8278305
Myosin light chain kinase inhibitor compounds, compositions and related methods of use
granted patentUS 8252756
Nucleic acid functionalized nanoparticles for therapeutic applications
granted patentUS 8246983
Encapsulated arsenic drugs
granted patentUS 8241862
Perinucleolar compartment as a cancer marker
granted patentUS 8198406
Methods and compositions for inhibiting angiogenesis
granted patentUS 8193151
Methods for treating atrial or ventricular arrhythmias
granted patentUS 8188096
Protein kinase targeted therapeutics
granted patentUS 8173628
Steroidal antiestrogens and antiandrogens and uses thereof
granted patentUS 8158627
Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
granted patentUS 8158658
Heteroaromatic selective inhibitors of neuronal nitric oxide synthase
granted patentUS 8138140
Self-assembling peptide amphiphiles and related methods for growth factor delivery
granted patentUS 8128930
Anti-ADDL antibodies and uses thereof
granted patentUS 8124583
Composition and method for self-assembly and mineralization of peptide-amphiphiles
granted patentUS 8114835
Self-assembling peptide amphiphiles for tissue engineering
granted patentUS 8114834
Self-assembling peptide amphiphiles
granted patentUS 8114830
Polypeptoid pulmonary surfactants
granted patentUS 8088774
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downre
granted patentUS 8080262
Encapsulated peptide amphiphile nanostructures
granted patentUS 8063047
Pyridazine compounds and methods
granted patentUS 8063014
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
granted patentUS 8058244
Cyclic peptide antitumor agents
granted patentUS 8048415
Compositions and methods for promoting or inhibiting angiogenesis
granted